Cargando…
Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups
BACKGROUND: PRDM5 is an epigenetic regulator that has been recognized as an important tumour suppressor gene. Silencing of PRDM5 by promoter hypermethylation has been demonstrated in several cancer types and PRDM5 loss results in upregulation of the Wnt pathway and increased cellular proliferation....
Autores principales: | Bond, Catherine E, Bettington, Mark L, Pearson, Sally-Ann, McKeone, Diane M, Leggett, Barbara A, Whitehall, Vicki LJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318154/ https://www.ncbi.nlm.nih.gov/pubmed/25613750 http://dx.doi.org/10.1186/s12885-015-1011-9 |
Ejemplares similares
-
Braf mutation induces rapid neoplastic transformation in the aged and aberrantly methylated intestinal epithelium
por: Fennell, Lochlan, et al.
Publicado: (2022) -
RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis
por: Bond, Catherine E., et al.
Publicado: (2016) -
Comparative analysis of Illumina Mouse Methylation BeadChip and reduced-representation bisulfite sequencing for routine DNA methylation analysis
por: Fennell, Lochlan J., et al.
Publicado: (2022) -
Isocitrate dehydrogenase 1 R132C mutation occurs exclusively in microsatellite stable colorectal cancers with the CpG island methylator phenotype
por: Whitehall, VLJ, et al.
Publicado: (2014) -
MLH1–93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF(V600E) mutation
por: Fennell, Lochlan J., et al.
Publicado: (2018)